

Scores at time of recommendation (March 9, 2026)
2021-07-12 Fortive announced a definitive agreement to acquire ServiceChannel for approximately $1.2 billion, expected to close in Q3 2021. ServiceChannel was projected to contribute roughly $125M in revenue for 2021 and enhance Fortive's recurring-revenue profile and guidance. [1]
The market began viewing Fortive as accelerating its shift into SaaS and recurring-revenue businesses, moving away from pure industrial operations toward software-enabled workflows. [1]
The stock moved from an earlier uptrend into consolidation as investors absorbed the strategic shift. [2]
2021-12-27 Fortive completed its acquisition of Provation, a healthcare workflow software company. Shortly after, the company reported Q4 and full-year 2021 results showing approximately 10% core revenue growth and EPS expansion. [3][4]
The Provation close reinforced the thesis that Fortive was building recurring-revenue software scale within its Advanced Healthcare Solutions portfolio. Investors increasingly framed Fortive as a hybrid industrial-plus-software compounder. [4]
Price action showed a constructive trend into early 2022, with periodic rallies on execution beats as operational results and software M&A supported multiple expansion. [4]
2023-10-23 Fortive announced an agreement to acquire EA Elektro-Automatik, an electronic test and measurement company serving energy storage, EV, and hydrogen markets, for approximately $1.45 billion with expected close in early Q1 2024. [6][7]
The market positioned this as strategic for capturing energy-transition end markets and potentially accretive to margins within the Precision Technologies portfolio. M&A was seen as essential to sustaining growth and tech exposure. [6]
M&A headlines triggered sharp upticks, though the stock largely remained in a multi-month range as broader industrial and tech cyclicality weighed on momentum. [6]
2024-01-03 Fortive closed the EA Elektro-Automatik acquisition with details disclosed in SEC filings regarding total consideration, goodwill, and financing. [8]
The close removed execution uncertainty and reinforced management's message of portfolio shaping, adding high-power test assets tied to secular growth drivers. Investor focus shifted toward integration and near-term financing. [8]
Brief volatility surrounded the financing and close, followed by resumed upward bias as investors incorporated the acquisition into forward estimates.
2024-01-31 Fortive reported Q4 and full-year 2023 results with FY2023 revenue of approximately $6.07B, messaging improved through-cycle consistency and Fortive Business System-driven margin progress. [5]
The company's messaging of predictable mid-single-digit core growth, mid-teens EPS and free cash flow compounding, and structural margin expansion via FBS strengthened the "quality compounder" perception. [5]
An earnings-driven rally rewarded margin expansion and consistent cash generation.
2024-04-24 Fortive reported Q1 2024 results: total revenue +4% (core +3%), record gross and operating margins, and raised full-year outlook for adjusted EPS and free cash flow. [9][10]
Results reinforced the view that FBS execution was delivering double-digit EPS and free cash flow compounding despite modest top-line growth. The narrative shifted toward a premium multiple reflecting margin resiliency and cash return capacity. [9]
A confirmation breakout followed as guidance was raised and results beat expectations.
2024 (reported 2025) Full-year 2024 summary showed modest revenue growth, adjusted operating margin expansion to a record of approximately 26.9%, strong free cash flow, and approximately $1.0B returned to shareholders through roughly 12M shares repurchased. [11]
Fortive was increasingly characterized as a cash-compounding, capital-allocating business. Investor emphasis shifted toward margin and buyback execution even as core revenue growth moderated. [11]
Medium-term uptrend was punctuated by rangebound trading as markets weighed growth against margin and capital return.
2024-09-04 Management announced the intention for James A. Lico to retire upon completion of the planned spin-off of the Precision Technologies segment, targeted for Q4 2025. [12]
The market began pricing in corporate-action complexity and leadership transition risk, alongside the possibility of value unlocking through a targeted separation. [12]
Volatility and consolidation entered the announced corporate-action period with sideways trading and spikes on corporate-action updates.
2025-05-27 Fortive declared a pro-rata dividend of 100% of Ralliant common stock to Fortive shareholders, with record date June 16, 2025 and distribution June 28, 2025. When-issued trading was expected June 25, with regular trading resuming June 30. [15]
Formal timing for the spin-off crystallized investor expectations around de-conglomeration and value unlocking. Fortive would emerge focused on Intelligent Operating Solutions and Advanced Healthcare Solutions. [15]
Pre-ex-date volatility reflected investor position adjustments ahead of the distribution and related tax and framing considerations.
2025-06-28 to 2025-06-30 The separation completed with Ralliant distributed to Fortive shareholders at a ratio of one Ralliant share per three Fortive shares. Ralliant began regular trading as RAL. Fortive appointed Olumide Soroye as President and CEO; James Lico retired and briefly served as senior advisor. Ralliant's results were treated as discontinued operations in Fortive reporting. [13][16][19]
After separation, investors re-modeled Fortive as a narrower, higher-margin, software-and-services-heavy company focused on IOS and AHS. The spin-off was framed as value-enhancing but introduced near-term execution and identity transition risk under new leadership. [13][16]
Immediate post-spin volatility and re-pricing established a new baseline. Typical short-term drawdown and rotation preceded consolidation as analysts re-estimated earnings and multiples.
2025-07-30 Fortive reported Q2 2025 results and began reporting Ralliant as discontinued operations following the distribution. Management provided post-separation outlook commentary for the retained company. [14]
Earnings season confirmed the accounting and operational reset. Investors focused on organic growth prospects of the retained IOS and AHS businesses and on capital-allocation capacity going forward. [14]
Rangebound trading continued as investors awaited execution cadence and the first full-period results from the refocused company.
2026-07-11 Fortive traded at 62.2.
By mid-2026, the public narrative centered on Fortive as a leaner, cash-generative operator with strong margin pedigree through FBS and a higher mix of recurring software and services in IOS and AHS. Growth was viewed as moderate but higher quality. Investors balanced margins and buybacks against top-line moderation and macro sensitivity. [9][11]
The chart phase was characterized by post-spin consolidation, trading in a multi-month range with episodic rallies on earnings and operational beats and occasional drawdowns on macro risk.
Fortive is not a glamor title - and that's exactly the point. The Group builds measurement technology, precision instruments and industrial software for customers who simply cannot afford to make mistakes. This creates high switching costs, stable margins and pricing power that is rare in the industry. Following the spin-off from Ralliant, Fortive is now more focused with two clear segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Q4 was further proof that the new structure is working. No hype, no moonshot - but a business model that delivers in difficult markets.
Fortive operates across test and measurement, industrial sensors and safety, connected worker and facilities software, and healthcare sterilization and clinical workflow. It faces competition from specialized instrumentation firms and larger industrial conglomerates, where the real battles are fought over product performance, software and services recurring revenue, and pricing power. The company carries three material constraints: supply chain and component cost swings that hit margins unpredictably, the weight of medical and data regulation in its healthcare division, and lingering post-spin financial, tax, and indemnity obligations that can tighten capital allocation and compress returns.
Fortive operates as a focused industrial-technology and healthcare-workflow company, split between Intelligent Operating Solutions and Advanced Healthcare Solutions. It competes against large diversified industrials and specialist vendors in diagnostics, instruments, industrial automation, and electronic instrumentation. The business faces familiar headwinds: cyclical industrial demand, competitors willing to spend aggressively on R&D and pricing, execution risk as the portfolio reshapes through M&A, and the ongoing regulatory and cybersecurity complexity that comes with healthcare and connected products.
| Company | Ticker |
|---|---|
| Danaher Corporation | DHR.NYSE |
| Emerson Electric Co. | EMR.NYSE |
| AMETEK, Inc. | AME.NYSE |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | Fortive Corp | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +0.38% | -0.36% | -0.29% |
| 3M | -0.67% | -3.96% | -4.33% |
| 6M | +11.28% | +11.19% | +3.61% |
| 1Y | +19.37% | +16.79% | +1.73% |
| 3Y | +10.01% | -43.73% | -58.23% |
| 5Y | +18.71% | -40.35% | -60.82% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 34.9 | 4.0 | 3.1 | 17.6 |
| 1Y ago | 22.7 | 2.8 | 1.7 | 11.5 |
| 3Y ago | 24.9 | 3.3 | 2.6 | 15.4 |
| 5Y ago | 10.3 | 3.5 | 2.6 | 15.0 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 0.06 USD | 0.10% | 0.11% |
| 2026 | 0.06 USD | 0.11% | |
| 2025 | 0.06 USD | 0.11% | |
| 2025 | 0.06 USD | 0.12% | |
| 2025 | 0.05 USD | 0.10% | |
| 2025 | 0.06 USD | 0.11% | |
| 2025 | 0.06 USD | 0.10% | |
| 2024 | 0.06 USD | 0.10% | |
| 2024 | 0.06 USD | 0.11% | |
| 2024 | 0.06 USD | 0.11% | |
| 2024 | 0.06 USD | 0.09% | |
| 2023 | 0.06 USD | 0.12% | |
| 2023 | 0.05 USD | 0.09% | |
| 2023 | 0.05 USD | 0.11% | |
| 2023 | 0.05 USD | 0.11% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 5.14B | 6.23B | 6.07B | 5.83B | 5.25B |
| Operating income (EBIT) | 908.90M | 1.12B | 1.13B | 971.80M | 831.50M |
| Net income | 579.20M | 832.90M | 865.80M | 755.20M | 608.40M |
| Free cash flow | 978.10M | 1.41B | 1.25B | 1.21B | 911.10M |
| Total assets | 11.74B | 17.02B | 16.91B | 15.89B | 16.47B |
| Equity | 6.45B | 10.19B | 10.32B | 9.68B | 9.51B |
| Net debt | 2.83B | 3.06B | 1.92B | 2.71B | 3.32B |